Bio-Imaging Technologies, Inc., d/b/a BioClinica, a global provider of clinical trial services, is challenging the industry to increase standards implementation for clinical trials at the Drug Information Association (DIA) 45th Annual Meeting on June 21-25 in San Diego (booth #315). Standards support has quickly become a key focus for the life science industry to streamline the clinical trial process and reduce costs. However, the complexity of the task and the resource requirements put implementing standards on the ‘someday list’ for many companies.
“Applicable standards are fully ready for use right now, making it vital that life science companies move forward with implementation,” said Mark Weinstein, President and CEO of BioClinica. “Unfortunately, this is often a difficult undertaking, especially when plates are full and budgets are challenged. Nevertheless, implementing clinical data standards will ultimately reduce costs and increase efficiency. We believe partners that understand clinical processes and standards are essential.”
Standards to support the acquisition, exchange and submission of clinical research data are paramount to increase the affordability and accessibility of medical research and improve the clinical trial process. Life science companies should prioritize incorporation of these standards into their data management practices to gain a competitive advantage, simplify processes and decrease costs during the clinical trial process. Vendor partners can play a vital role to assist their clients to stay ahead of the curve and reap the rewards.
“The time has come to use technology more strategically,” continued Weinstein. “The clinical research process will become more efficient only when we collectively support the development of standards, as well as their widespread adoption and implementation.”
Date: June 19, 2009
Filed Under: Drug Discovery